Host-at-a-Glance Name: Gil Blander What he does: Founder and CSO Company: InsideTracker Noteworthy: Expert in longevity, nutrition, and personalized health optimization Host-at-a-Glance Name: Ashley Reaver What she does: Lead Nutrition Scientist Company: InsideTracker Noteworthy: Specializes in metabolism, nutrition, and biomarker-based health strategies Episode highlights: [00:00:00] Introduction [00:02:02] Understanding GLP-1 Hormones [00:04:26] GLP-1 Receptor Agonists: Mechanism and Benefits [00:06:50] Impact of GLP-1 on Weight and Health [00:21:16] Side Effects and Considerations of GLP-1 Agonists [00:26:31] The Future of GLP-1 Agonists [00:34:54] Exploring Wearables for Health [00:36:08] Choosing the Right Wearable [00:40:29] Wearables for Detecting Illness and Falls [00:47:12] Conclusion and Final Thoughts Key Insights GLP-1 Agonists: A Breakthrough for Weight and Metabolic Health GLP-1 agonists, originally developed for type 2 diabetes, have become a game-changer for weight loss, appetite control, and longevity
A major study, published in 2025, on the link between the intake of various food groups and risk of overweight and obesity found diets rich in whole grains, legumes, nuts, and fruit are linked with a lower risk of overweight and obesity (8)
HAP were obtained during open heart surgery from patients who suffered from severe coronary heart disease
The combination of appetite control from Supresa with GLP-1 support from Eriomin creates an intriguing natural approach to weight management
Glucagon is traditionally known as the hormone that raises blood sugar when it drops too low, but it also plays a crucial role in energy expenditure and fat metabolism
